Travere Therapeutics Inc (TVTX)
5.75
-0.10
(-1.79%)
USD |
NASDAQ |
Apr 23, 16:00
5.75
0.00 (0.00%)
After-Hours: 16:16
Travere Therapeutics Price: 5.75 for April 23, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Apr 22, 2024 | 5.77 | 5.935 | 5.705 | 5.855 | 893770.0 |
Apr 19, 2024 | 5.73 | 5.91 | 5.575 | 5.72 | 946781.0 |
Apr 18, 2024 | 5.97 | 6.02 | 5.775 | 5.80 | 972749.0 |
Apr 17, 2024 | 6.24 | 6.34 | 5.94 | 5.99 | 1.314M |
Apr 16, 2024 | 6.23 | 6.36 | 6.113 | 6.15 | 792112.0 |
Apr 15, 2024 | 6.33 | 6.49 | 6.19 | 6.32 | 1.548M |
Apr 12, 2024 | 6.65 | 6.70 | 6.25 | 6.37 | 1.410M |
Apr 11, 2024 | 6.74 | 6.845 | 6.52 | 6.69 | 1.966M |
Apr 10, 2024 | 6.84 | 6.84 | 6.430 | 6.67 | 3.591M |
Apr 09, 2024 | 7.02 | 7.26 | 6.815 | 6.86 | 755112.0 |
Apr 08, 2024 | 7.07 | 7.15 | 6.935 | 6.96 | 534602.0 |
Apr 05, 2024 | 6.84 | 7.13 | 6.65 | 7.04 | 715668.0 |
Apr 04, 2024 | 7.09 | 7.17 | 6.92 | 6.95 | 1.082M |
Apr 03, 2024 | 6.97 | 7.15 | 6.85 | 6.98 | 1.254M |
Apr 02, 2024 | 7.34 | 7.34 | 7.00 | 7.04 | 1.052M |
Apr 01, 2024 | 7.71 | 7.77 | 7.24 | 7.31 | 1.070M |
Mar 28, 2024 | 7.74 | 7.98 | 7.41 | 7.71 | 776017.0 |
Mar 27, 2024 | 7.11 | 8.06 | 7.11 | 7.67 | 1.104M |
Mar 26, 2024 | 7.86 | 7.95 | 7.54 | 7.57 | 988583.0 |
Mar 25, 2024 | 8.02 | 8.115 | 7.69 | 7.69 | 625928.0 |
Mar 22, 2024 | 7.95 | 8.14 | 7.83 | 7.88 | 952364.0 |
Mar 21, 2024 | 7.88 | 8.41 | 7.72 | 8.09 | 1.030M |
Mar 20, 2024 | 7.41 | 7.84 | 7.34 | 7.76 | 1.002M |
Mar 19, 2024 | 7.13 | 7.52 | 7.11 | 7.48 | 1.335M |
Mar 18, 2024 | 7.43 | 7.47 | 7.14 | 7.18 | 1.165M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
5.44
Minimum
Nov 09 2023
31.77
Maximum
Feb 05 2021
19.04
Average
19.62
Median
Price Benchmarks
AtriCure Inc | 23.16 |
Bio-Rad Laboratories Inc | 285.46 |
Artivion Inc | 20.78 |
Shockwave Medical Inc | 328.48 |
Perspective Therapeutics Inc | 1.70 |
Price Related Metrics
PS Ratio | 2.147 |
Price to Book Value | 2.179 |
Earnings Yield | -28.00% |
Market Cap | 437.57M |